GÜRKAN, E. Et Al. 2014. Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers. Diabetes Research and Clinical Practice , vol.106, no.3 , 567-575.

GÜRKAN, E., Tarkun, I., ŞAHİN, T., ARSLAN, B., & CANTÜRK, Z., (2014). Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers. Diabetes Research and Clinical Practice , vol.106, no.3, 567-575.

GÜRKAN, EREN Et Al. "Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers," Diabetes Research and Clinical Practice , vol.106, no.3, 567-575, 2014

GÜRKAN, EREN Et Al. "Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers." Diabetes Research and Clinical Practice , vol.106, no.3, pp.567-575, 2014

GÜRKAN, E. Et Al. (2014) . "Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers." Diabetes Research and Clinical Practice , vol.106, no.3, pp.567-575.

@article{article, author={EREN GÜRKAN Et Al. }, title={Evaluation of exenatide versus insulin glargine for the impact on endothelial functions and cardiovascular risk markers}, journal={Diabetes Research and Clinical Practice}, year=2014, pages={567-575} }